Internal hemorrhoids
Conditions
Interventions
Treatment group:Internal hemorrhoids were treated with 3% polydocarol injection foam hardener
Control group:Other sclerosing agents treat internal hemorrhoids(For example, laurosol)
Sponsors
Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-75 years old, male or female; 2. Patients who meet the indications for microscopic treatment of internal hemorrhoids and need elective or emergency treatment: patients with stage I, II, and III hemorrhoids (especially those with bleeding and prolapse) and some internal hemorrhoids combined with uncomplicated mixed syndromes; 3. The patient can follow the follow-up plan; Able to objectively describe symptoms and actively cooperate with the completion of the scale; 4. Sign the informed consent form; 5. Those who have an expected survival time of at least one year; 6. Colonoscopy excludes other intestinal diseases.
Exclusion criteria
Exclusion criteria: 1. Patients with rectal and anal diseases with serious complications (such as incarceration, ulceration, infection, etc.), severe external hemorrhoids, anal fissures; 2. Patients with severe bleeding tendency (relative) and severe heart, lung, liver, brain, and renal failure are not suitable for endoscopy and rectal and anal function examination; 3. Patients who have previously performed rectal and anal surgery and minimally invasive treatment; 4. There are other intestinal diseases, such as ulcerative colitis, Crohn's disease and anal lesions 5. Dentate line area with unexplained ulcer; 6. Pregnant and lactating women; 7. Unable to cooperate with the examination and follow-up for reasons such as lack of cognitive ability; 8. Combined with other serious systemic diseases such as advanced tumors; 9. People with an expected survival time of less than one year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the effects before and after endoscopic treatment for patients;Effective rate;Rebleeding rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate;Complication rate; | — |
Countries
China
Contacts
Public ContactDi Zhang
Sichuan Provincial People's Hospital
Outcome results
None listed